EUVIMEDEUVIMED entdecken
Open Access

Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis

Julian Villar, Jack H Short iD, Geoffrey Lighthall

Infectious Diseases: Research and Treatment · 2019-01 · 12

DOI: 10.1177/1178633719862776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Diseases: Research and Treatment, online erschienen am 06.08.2019. Verfasst von Julian Villar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA, USA. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To measure the relationship between lactate and mortality in hospital inpatients. Main outcomes of interest were 3-day, 30-day, and 1-year all-cause mortality.

Design

Retrospective cohort study, October 2011 to September 2013.

Setting

University-affiliated US Veterans Affairs Hospital. Patients: All inpatients with lactate level measured during the study period.

Measurements

Analysis of peak lactate level (mmol/L) during the most recent admission for patients who died, and peak lactate level during an admission for surviving patients. Covariates including sepsis, ICU admission, code blue and rapid response calls, medical vs surgical ward, liver disease, kidney disease, and hospice status were recorded.

Results

In total, 3325 inpatients were included; 564 patients had sepsis. Median lactate 1.7 mmol/L (interquartile range [IQR] 1.2-2.6). The 3-day, 30-day, and 1-year mortality were 2.5%, 10%, and 24%, respectively. A lactate level cutoff of ⩾4 mmol/L had best test characteristics (sensitivity 52.4%, specificity 91.4%) to predict increased 3-day mortality. Unadjusted risk ratio of death in 3 days for lactate ⩾4 was 10.3 (95% confidence interval [CI] 6.8-15.7). Patients with sepsis had a consistently higher risk of death compared with patients without sepsis for any given level of lactate. Adjusted odds ratio (OR) of 3-day mortality for lactate ⩾4 was 7.6 (95% CI 4.6-12.5); 30-day mortality was 2.6 (95% CI 1.9-3.6); and 1-year mortality was 1.8 (95% CI 1.4-2.6). Lactates in the normal range (

Schlagwörter

Stichwörter der Autor:innen

Lactic acidosiscritical caremortalityprognosticationsepsisshock

Autor:innen und Institutionen

  • Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Anesthesia, Pain and Perioperative Medicine, Stanford University School of Medicine, Stanford, CA, USA.

ORCID-Profile: Jack H Short

Zitieren

APA

Villar, J., Short, J. H., & Lighthall, G. (2019). Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis. Infectious Diseases: Research and Treatment, 12. https://doi.org/10.1177/1178633719862776

Vancouver

Villar J, Short JH, Lighthall G. Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis. Infectious Diseases: Research and Treatment. 2019;12. doi:10.1177/1178633719862776

BibTeX
@article{Villar2019,
  author = {Villar, Julian and Short, Jack H and Lighthall, Geoffrey},
  title = {Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis},
  journal = {Infectious Diseases: Research and Treatment},
  year = {2019},
  volume = {12},
  doi = {10.1177/1178633719862776}
}
Kostenlos starten →